Aprocitentan is an orally active, dual endothelin (ET) receptor antagonist developed for the treatment of hypertension in which, despite available treatments, a medical need exists for drugs with a new mechanism of action.
仅供研究使用。 我们不向患者出售。
名称 | Aprocitentan |
---|---|
Iupac 化学名称 | N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]sulfuric diamide |
同义词 | Aprocitentan; ACT-132577; ACT 132577; ACT132577; Despropyl Macitentan. |
英文同义词 | Aprocitentan; ACT-132577; ACT 132577; ACT132577; Despropyl Macitentan. |
分子式 | C16H14Br2N6O4S |
分子量 | 546.19 |
Smile | BrC1=CC=C(C=C1)C=1C(=NC=NC1OCCOC1=NC=C(C=N1)Br)NS(N)(=O)=O |
InChiKey | DKULOVKANLVDEA-UHFFFAOYSA-N |
InChi | InChI=1S/C16H14Br2N6O4S/c17-11-3-1-10(2-4-11)13-14(24-29(19,25)26)22-9-23-15(13)27-5-6-28-16-20-7-12(18)8-21-16/h1-4,7-9H,5-6H2,(H2,19,25,26)(H,22,23,24) |
Cas号 | 1103522-45-7 |
相关CAS号 |
包装 | 价格 | 库存 | 纯度 | 备货期 |
---|---|---|---|---|
大货 | 询价 | 询价 | 询价 |
外观性状 | 类白色至白色固体 |
---|---|
纯度 | 98% Min. |
存储 | 短期可在0-4度保存,数天至数月;长期可在-20度保存三年。 |
可溶性 | 可溶于DMSO;不溶于水 |
处理方式 | |
运输条件 | 可在常温下运输 |
海关编码 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |
[1]. Iglarz M, et al. Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist. J Pharmacol Exp Ther. 2008 Dec;327(3):736-45.
[2]. Zhang J, et al. Pharmacokinetic study of ACT-132577 in rat plasma by ultra performance liquid chromatography-tandem mass spectrometry. Int J Clin Exp Med. 2015 Oct 15;8(10):18420-6